// App-Quantinova.ai

2614 : Hydroxychloroquine Initiation Dosing Trends and Predictors in Systemic Lupus Erythematosus

Researchers

Presenter

  • April Jorge

Principal Investigators

  • Leo Lu

  • Yuqing Zhang

  • Sharan K. Rai

  • Lucy H. Young

  • Ronald B. Melles

  • Michael F. Marmor

  • Karen H. Costenbader

  • Rosalind Ramsey-Goldman

  • S. Sam Lim

  • John M. Esdaile

  • Ann E. Clarke

  • Murray Urowitz

  • Anca Askanase

  • Cynthia Aranow

  • Michelle Petri

  • Hyon K. Choi

Medical Centers

  • Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

  • Allergy, Immunology, and Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

  • Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

  • Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

  • Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA

  • Department of Ophthalmology, Kaiser Permanente, Redwood City, CA

  • Department of Ophthalmology and Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  • Northwestern University, Chicago, IL

  • Medicine/Rheumatology, Emory University School of Medicine, Atlanta, GA

  • Arthritis Research Centre of Canada, Richmond, BC, Canada

  • Division of Nephrology, University of Calgary, Calgary, AB, Canada

  • Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

  • Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, NY

  • Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Manhasset, NY

  • Division of Rheumatology, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Body mass index

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved